Patients | Number of pts | Age (years) | CC-16 (ng/ml) | CRP (mg/l) | Hb (g/dl) | Fe (µg/dl) |
COPD stage I | 6 | 52.0±10.2* | 4.48±2.58 | 5.87±1.93 | 13.58±1.08 | 148.50±38.17 |
COPD stage II | 20 | 66.1±8.1* | 5.58±3.34 | 7.06±3.35 | 14.,02±1.12 | 104.30±31.38 |
COPD stage III | 12 | 62.2±11.2 | 6.87±4.68 | 7.70±3.65 | 14.38±1.38 | 112.5±61.48 |
COPD stage IV | 23 | 64.6±9.6* | 6.33±2.84 | 10.42±9.83 | 14.66±2.00 | 125.32±53.08 |
COPD category A | 19 | 60.4±10.5 | 4.73±2.47 | 6.60±2.97 | 13.8±0.91 | 116.32±39.00 |
COPD category B | 8 | 67.9±7.7 | 7.05±4.49 | 11.1±11.0 | 14.25±1.43 | 103.50±36.77 |
COPD category C | 7 | 59.7±10.0 | 5.73±3.90 | 7.20±2.82 | 14.30±1.44 | 106.14±42.82 |
COPD category D | 27 | 64.8±9.0 | 6.73±3.42 | 8.98±7.31 | 14.71±1.92 | 124.37±58.81 |
All | 61 | 63.5±10.1 | 6,01±3.35 | 8.25±6.57 | 14.28±1.54 | 117.61±48.03 |